Legislative (DQSA, USP)
Read the Drug Quality and Security Act (DQSA) law which grants the FDA regulatory authority over compounded drugs.
Mobius teamed up with ASORN to present an informative webinar discussing DQSA and how it affects your business, featuring two industry experts answering questions and providing important details about the law.
DQSA Risks of Pharmacy Compounding
This important document thoroughly discusses the risks associated with compounded drugs.
FREE EDUCATIONAL RESOURCE
USP <800> Hazardous Drugs: Handling in Ophthalmic Healthcare Settings.
USP 800 NIOSH Alert
Both traditional medications and bioengineered drugs can be hazardous to health care workers who must handle them. This NIOSH Alert will help make workers and employers more aware of these hazards and provide the tools for preventing exposures.
ASORN Wall Chart
Top tips for safe handling, use, and disposal of Ophthalmic Mitomycin-C. Provide by American Society of Ophthalmic Registered Nurses(ASORN) for educational purposes.
ASORN MMC Guide
Independent authors’ guidelines for the safe use and handling of mitomycin C in ophthalmic practices.
IJO Article – Hyaluronidase Clinical Trial
Results of a clinical trial investigating the effect of hyaluronidase usage on the quality of sub-Tenon’s anesthesia for phacoemulsification.
WMT-004 Rev 01/2018